US 11332760
Compositions and methods for genomic editing by insertion of donor polynucleotides
granted A61KA61K48/00A61K48/0025
Quick answer
US patent 11332760 (Compositions and methods for genomic editing by insertion of donor polynucleotides) held by CRISPR THERAPEUTICS AG expires Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CRISPR THERAPEUTICS AG
- Grant date
- Tue May 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K48/00, A61K48/0025